Transcatheter Aortic Valve Replacement Clinical Trial
Official title:
Ultrasound-guided Femoral Puncture to Reduce Access- Related Complications After TAVR: (ACCESS-TAVR SIRIO)
Recent observational data showed a marked reduction of vascular and bleeding complications by the use of ultrasound(US)-guided femoral artery puncture to gain the vascular access and guide the implantation of the Perclose ProGlide® vascular closure system. We aimed to compare in a 1:1 randomized fashion the effect of US-guided femoral puncture and Perclose ProGlide® implantation optimization vs fluoroscopy-guided puncture followed by Perclose ProGlide/ ProStyle implantation (standard approach) during TAVR.
Transfemoral approach has become the standard route for a transcatheter aortic valve replacement (TAVR) procedure. Despite the technology improvements, vascular complications and access-related bleeding are frequently observed after TAVR and emerge predominantly within 30 days after TAVR. Recent observational data showed a marked reduction of vascular and bleeding complications by the use of ultrasound(US)- guided femoral artery puncture to gain the vascular access and guide the implantation of the Perclose ProGlide® vascular closure system. We aimed to compare in a 1:1 randomized fashion the effect of US-guided femoral puncture and Perclose ProGlide® implantation optimization vs fluoroscopy-guided puncture followed by Perclose ProGlide/ ProStyle implantation (standard approach) during TAVR. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05465655 -
Cara CDRM (Conduction Disturbance Risk Monitor) 2.0
|
N/A | |
| Recruiting |
NCT04870424 -
Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
|
Phase 3 | |
| Completed |
NCT02758964 -
Evaluation of Cerebral Thrombembolism After TAVR
|
||
| Recruiting |
NCT05758701 -
CT TAVR Abdomen Study
|
Phase 4 | |
| Active, not recruiting |
NCT04281771 -
Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI
|
N/A | |
| Enrolling by invitation |
NCT06212050 -
Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
|
||
| Recruiting |
NCT04573049 -
The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement
|
Phase 4 | |
| Recruiting |
NCT05235555 -
EffecTAVI Registry
|
||
| Completed |
NCT05082337 -
The SAVVY Guidewire in Transcatheter Aortic Valve Replacement Procedures
|
N/A | |
| Completed |
NCT01627691 -
REPRISE II: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System
|
N/A | |
| Recruiting |
NCT05075590 -
Coronary Access After Supra-Annular THV Implantation
|
N/A | |
| Completed |
NCT01651780 -
Open-label, Randomized Trial in Patients Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH
|
Phase 3 | |
| Recruiting |
NCT05259241 -
ADAPT Transcatheter Aortic Valve Intervention (TAVI & Chronic Total Occlusion Percutaneous Coronary Intervention (CTO PCI)
|
N/A | |
| Completed |
NCT04489914 -
Observational Study on the Application of High-Flow Therapy After Percutaneous Transfemoral Aortic Valve Replacement
|
||
| Recruiting |
NCT03649594 -
Risk Stratification Post TAVI Using TEG
|
||
| Completed |
NCT04659538 -
The CAPTIS® Study - Embolic Protection in TAVR
|
N/A | |
| Recruiting |
NCT04107038 -
Monitored Anesthesia Care vs. General Anesthesia for Transcatheter Aortic Valve Replacement
|
N/A | |
| Withdrawn |
NCT04268160 -
GPx Activity in Subjects With Aortic Stenosis Undergoing TAVR
|
||
| Recruiting |
NCT02812953 -
Biological Collection and Registry of Patients Who Will Have a TAVR (Transcatheter Aortic Valve Replacement) Intervention
|
||
| Recruiting |
NCT05217888 -
The Sentinel Registry
|